Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifitegrast vs Systane after LipiFlow in MGD
NCT05594745Phase 4Completed
- Sponsor
- Tauber Eye Center
- Start
- Mar 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lifitegrast in dry eye disease (DED), meibomian gland dysfunction (MGD), sponsored by Tauber Eye Center. Started Mar 2021; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye disease (DED)meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NCT05594745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05594745.